Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus

By Salvadó Laia   Serrano-Marco Lucía   Barroso Emma   Palomer Xavier   Vázquez-Carrera Manuel  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 209-223

Informa Healthcare

Access to resources Recommend Favorite

Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 2, 2002-07 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2

By Oliveira Joana Moitinho   Rebuffat Sandra A.   Gasa Rosa   Gomis Ramon  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 8, 2014-01 ,pp. : 613-620

NRC Research Press

Access to resources Recommend Favorite

Islet cell transplantation for type 1 diabetes?

By  

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Islet cell transplantation in type-1 diabetes - trials show promise

By  

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite